Business
Biogen consolidates global felzartamab rights via USD 850m agreement with TJ Biopharma
Biogen (Nasdaq: BIIB) has entered into a definitive agreement to acquire China-based TJ Biopharma's exclusive rights to felzartamab in the Greater China...
Asahi Kasei expands antiviral pipeline with completed acquisition of Aicuris Anti-infective Cures AG
Asahi Kasei Targets Antiviral Pipeline Expansion via Acquisition of Aicuris Anti-infective Cures AG
Eli Lilly building in vivo CAR-T capabilities via USD 7b acquisition of Kelonia Therapeutics
Eli Lilly and Company (NYSE: LLY) has agreed to acquire US-based Kelonia Therapeutics, Inc., a private Boston-headquartered gene therapy company, for up to...
Landmark Bio secures USD 18.3m ARPA-H funding for extracellular vesicle manufacturing
Landmark Bio, a contract development and manufacturing organization (CDMO) based in Watertown, Massachusetts, has secured up to USD 18.3 million in...
Achieve Life Sciences secures USD 354m private placement for cytisinicline nicotine dependence program
Achieve Life Sciences (NASDAQ: ACHV), a specialty pharmaceutical company headquartered in Bothell, Washington, has announced a private placement of up to...
UCB acquires Neurona Therapeutics for USD 1.15b to expand epilepsy regenerative medicine platform
Belgium-based UCB (Euronext Brussels: UCB) has entered into a definitive agreement to acquire US-based Neurona Therapeutics, a privately held clinical-stage...
MeiraGTx Holdings raises USD 100m in underwritten public offering
MeiraGTx Holdings plc (Nasdaq: MGTX) announced a USD 100 million underwritten public offering of ordinary shares, with proceeds directed toward extending...
Acurx closes USD 7.1m share offering to support antibiotic development
Acurx Pharmaceuticals (NASDAQ: ACXP), a Staten Island, New York-based biopharmaceutical company developing small molecule antibiotics for difficult-to-treat...
Kailera sets IPO record with Nasdaq listing set to raise at least USD 625m
Kailera Therapeutics (Nasdaq: KLRA), a Waltham, Massachusetts-based clinical-stage biotechnology company focused on obesity treatment, priced its initial...
Mount Sinai Health System adopts Sophia Genetics SOPHiA DDM platform for cancer genomics sequencing
Mount Sinai Health System has adopted the SOPHiA DDM platform from Sophia Genetics (NASDAQ: SOPH), a cloud-native AI genomics company, to support...
Trevi Therapeutics raises USD 150 million in underwritten public offering of common stock
Trevi Therapeutics (NASDAQ: TRVI), a New Haven, Connecticut-based clinical-stage biopharmaceutical company focused on chronic cough, has priced an...
MeiraGTx reacquires botaretigene sparoparvovec from J&J for USD 25m upfront
MeiraGTx (Nasdaq: MGTX) has acquired all interests in botaretigene sparoparvovec (bota-vec), an AAV-based gene therapy for X-linked retinitis pigmentosa,...
Aligos hands pevifoscorvir license to Xiamen Amoytop in USD 445m deal
Aligos Therapeutics (Nasdaq: ALGS) has entered an exclusive license agreement with Xiamen Amoytop Biotech Co., Ltd. covering pevifoscorvir sodium, an oral...
RemeGene receives USD 650m upfront fee from AbbVie
RemeGen Co. (HKEX: 9995) confirmed on April 15 that it has received the USD 650 million upfront payment from AbbVie (NYSE: ABBV) under the exclusive license...
PrecisionLife and Ovation collaborate on AI-driven GLP-1 stratification test
PrecisionLife and Ovation have entered a collaboration agreement to commercialize a GLP-1 stratification test platform combining AI-driven genomic analytics...
The AllSci Brief
Systematic R&D and deal news. Daily.